Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

NCT00402805 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00402805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2007
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza vaccines, lung transplantation